Next Article in Journal
Risk Factors for Venous Thromboembolism in Endometrial Cancer
Previous Article in Journal
Chest Wall Toxicity after Stereotactic Radiation in Early Lung Cancer: A Systematic Review
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Current Oncology
Volume 27
Issue 4
10.3747/co.27.6193
curroncol-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Does Dissemination of Guidelines Alone Increase the Use of Palliative Single-Fraction Radiotherapy? Initial Report of a Longitudinal Change Management Campaign at a Provincial Cancer Program

by
J.O. Kim
1,*,
N. Hanumanthappa
1,
Y.T. Chung
2,
J. Beck
3,
R. Koul
1,
B. Bashir
1,
A. Cooke
1,
A. Dubey
1,
J. Butler
1,
M. Nashed
1,
W. Hunter
4 and
A. Ong
1
1
Radiation Oncology, CancerCare Manitoba, Winnipeg, MB, Canada
2
Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada
3
Medical Physics, CancerCare Manitoba, Winnipeg, MB, Canada
4
Radiation Oncology, Western Manitoba Cancer Centre, Brandon, MB, Canada
*
Author to whom correspondence should be addressed.
Curr. Oncol. 2020, 27(4), 190-197; https://doi.org/10.3747/co.27.6193
Submission received: 6 May 2020 / Revised: 9 June 2020 / Accepted: 7 July 2020 / Published: 1 August 2020

Abstract

Background: Despite level 1 evidence demonstrating the equivalence of single-fraction radiotherapy (SFRT) and multiple-fraction radiotherapy (MFRT) for the palliation of painful bone metastases, SFRT remains underused. In 2015, to encourage the sustainable use of palliative radiation oncology resources, CancerCare Manitoba disseminated, to each radiation oncologist in Manitoba, guidelines from Choosing Wisely Canada (CWC) that recommend SFRT. We assessed whether dissemination of the guidelines influenced SFRT use in Manitoba in 2016, and we identified factors associated with MFRT. Methods: All patients treated with palliative radiotherapy for bone metastasis in Manitoba from 1 January 2016 to 31 December 2016 were identified from the provincial radiotherapy database. Patient, treatment, and disease characteristics were extracted from the electronic medical record and tabulated by fractionation schedule. Univariable and multivariable logistic regression analyses were performed to identify risk factors associated with MFRT. Results: In 2016, 807 patients (mean age: 70 years; range: 35–96 years) received palliative radiotherapy for bone metastasis, with 69% of the patients having uncomplicated bone metastasis. The most common primary malignancies were prostate (27.1%), lung (20.6%), and breast cancer (15.9%). In 62% of cases, MFRT was used—a proportion that was unchanged from 2015. On multivariable analysis, a gastrointestinal [odds ratio (OR): 5.3] or lung primary (OR: 3.3), complicated bone metastasis (OR: 4.3), and treatment at a subsidiary site (or: 4.4) increased the odds of MFRT use. Conclusions: Dissemination of cwc recommendations alone did not increase SFRT use by radiation oncologists in 2016. A more comprehensive knowledge translation effort is therefore warranted and is now underway to encourage increased uptake of SFRT in Manitoba.
Keywords: single-fraction radiotherapy; bone metastasis; palliation; knowledge translation; guideline adherence; quality improvement; behaviour change single-fraction radiotherapy; bone metastasis; palliation; knowledge translation; guideline adherence; quality improvement; behaviour change

Share and Cite

MDPI and ACS Style

Kim, J.O.; Hanumanthappa, N.; Chung, Y.T.; Beck, J.; Koul, R.; Bashir, B.; Cooke, A.; Dubey, A.; Butler, J.; Nashed, M.; et al. Does Dissemination of Guidelines Alone Increase the Use of Palliative Single-Fraction Radiotherapy? Initial Report of a Longitudinal Change Management Campaign at a Provincial Cancer Program. Curr. Oncol. 2020, 27, 190-197. https://doi.org/10.3747/co.27.6193

AMA Style

Kim JO, Hanumanthappa N, Chung YT, Beck J, Koul R, Bashir B, Cooke A, Dubey A, Butler J, Nashed M, et al. Does Dissemination of Guidelines Alone Increase the Use of Palliative Single-Fraction Radiotherapy? Initial Report of a Longitudinal Change Management Campaign at a Provincial Cancer Program. Current Oncology. 2020; 27(4):190-197. https://doi.org/10.3747/co.27.6193

Chicago/Turabian Style

Kim, J.O., N. Hanumanthappa, Y.T. Chung, J. Beck, R. Koul, B. Bashir, A. Cooke, A. Dubey, J. Butler, M. Nashed, and et al. 2020. "Does Dissemination of Guidelines Alone Increase the Use of Palliative Single-Fraction Radiotherapy? Initial Report of a Longitudinal Change Management Campaign at a Provincial Cancer Program" Current Oncology 27, no. 4: 190-197. https://doi.org/10.3747/co.27.6193

APA Style

Kim, J. O., Hanumanthappa, N., Chung, Y. T., Beck, J., Koul, R., Bashir, B., Cooke, A., Dubey, A., Butler, J., Nashed, M., Hunter, W., & Ong, A. (2020). Does Dissemination of Guidelines Alone Increase the Use of Palliative Single-Fraction Radiotherapy? Initial Report of a Longitudinal Change Management Campaign at a Provincial Cancer Program. Current Oncology, 27(4), 190-197. https://doi.org/10.3747/co.27.6193

Article Metrics

Back to TopTop